Histoid leprosy: clinical and histopathological analysis of patients in follow‐up in University Clinical Hospital of endemic country
Adult
Male
Endemic Diseases
Patient Selection
Biopsy, Needle
Middle Aged
Ambulatory Care Facilities
Immunohistochemistry
Risk Assessment
Severity of Illness Index
3. Good health
Cohort Studies
Hospitals, University
Leprosy, Lepromatous
03 medical and health sciences
Age Distribution
0302 clinical medicine
Prevalence
Humans
Female
Physical Examination
Brazil
Retrospective Studies
DOI:
10.1111/ijd.13926
Publication Date:
2018-01-31T16:24:51Z
AUTHORS (6)
ABSTRACT
AbstractBackgroundHistoid leprosy (HL) is a rare form of lepromatous leprosy, characterized by hyperchromic indurated nodules above normal skin. Its main histopathological aspect is spindle cells. Because it may simulate other aspects, such as dermatofibroma and neurofibroma, histoid leprosy poses itself as a diagnostic challenge.MethodsThis is a retrospective study with all patients having been selected from the leprosy clinic of the Hospital das Clínicas da Universidade de São Paulo from 2006 to 2016.ResultsThere were 12 patients in this study, eight in the histoid group and four in the lepromatous leprosy group. The prevalence of HL was 1.12% in all leprosy subjects. All individuals from HL group were “de novo” cases, and the histopathological analysis of skin lesions presented spindle cells generating a storiform pattern. Immunohistochemistry for CD68, vimentin, and anti‐BCG were positive in all 12 cases. Factor XIIIa was visualized only in the papillary dermis, and S100 protein was negative in all biopsies. Smooth‐muscle actin was present in 62.5% of the HL samples.ConclusionThe prevalence of HL was similar to previous reports. However, all histoid patients were “de novo” cases, differing from published studies. Fusocellular macrophage transformation could be explained by the differences in cytoskeleton proteins expressed in histoid lesions in comparison to other leprosy variants, with emphasis on vimentin and smooth muscle actin.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....